Pursuant to Regulation 30 read with Schedule III Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Aksh Optifibre has informed that CARE has improved the Long Term Rating from ‘BBB-‘ to ‘BBB’ and Short Term Rating from ‘A3’ to ‘A3+’.
The above information is a part of company’s filings submitted to BSE.